Evidence map›Paper›PMID 28077632›Full record

ArticleJournal of virology2017

Phyloepidemiological Analysis Reveals that Viral Divergence Led to the Paucity of Simian Immunodeficiency Virus SIVmus/gsn/mon Infections in Wild Populations.

Fabian Schmidt, Florian Liegeois, Edward J D Greenwood, Matthew LeBreton, James Lester, Luc Deleplancque, Martine Peeters, Avelin Aghokeng, Ubald Tamoufe, Joseph L D Diffo and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Fabian SchmidtLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom fs335@me.com.ORCID http://orcid.org/0000-0001-7731-6685
Florian LiegeoisUMI233/INSERM1175, IRD, and University of Montpellier, Montpellier, France.
Edward J D GreenwoodLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Matthew LeBretonMosaic, Yaoundé, Cameroon.
James LesterLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Luc DeleplancqueLaboratoire de Rétrovirologie, Centre International de Recherches Médicales de Franceville, Franceville, Gabon.
Martine PeetersUMI233/INSERM1175, IRD, and University of Montpellier, Montpellier, France.
Avelin AghokengVirology Laboratory CREMER-IMPM, Yaoundé, Cameroon.
Ubald TamoufeMetabiota, Yaoundé, Cameroon, and San Francisco, Cameroon.
Joseph L D DiffoMetabiota, Yaoundé, Cameroon, and San Francisco, Cameroon.
Jean M TakuoMetabiota, Yaoundé, Cameroon, and San Francisco, Cameroon.
Nathan D WolfeMetabiota, Yaoundé, Cameroon, and San Francisco, Cameroon.
Eric LeroyCentre International de Recherches Médicales de Franceville, Franceville, Gabon.
François RouetLaboratoire de Rétrovirologie, Centre International de Recherches Médicales de Franceville, Franceville, Gabon.
Jonathan L HeeneyLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GBCentre International de Recherches Médicales de Franceville · GAMetabiota (Cameroon) · CMInserm · FRGlobal Viral · USInstitut de Recherches Médicales et d’Etudes des Plantes Médicinales · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) is the result of cross-species transmission of simian immunodeficiency virus from chimpanzees (SIVcpz). SIVcpz is a chimeric virus which shares common ancestors with viruses infecting red-capped mangabeys and a subset of guenon species. The epidemiology of SIV infection in hominoids is characterized by low prevalences and an uneven geographic distribution. Surveys in Cameroon indicated that two closely related members of the guenon species subset, mustached guenons and greater spot-nosed guenons, infected with SIVmus and SIVgsn, respectively, also have low rates of SIV infections in their populations. Compared to that for other monkeys, including red-capped mangabeys and closely related guenon species, such an epidemiology is unusual. By intensifying sampling of geographically distinct populations of mustached and greater spot-nosed guenons in Gabon and including large sample sets of mona guenons from Cameroon, we add strong support to the hypothesis that the paucity of SIV infections in wild populations is a general feature of this monophyletic group of viruses. Furthermore, comparative phylogenetic analysis reveals that this phenotype is a feature of this group of viruses infecting phylogenetically disparate hosts, suggesting that this epidemiological phenotype results from infection with these HIV-1-related viruses rather than from a common host factor. Thus, these HIV-1-related viruses, i.e., SIVcpz and the guenon viruses which share an ancestor with part of the SIVcpz genome, have an epidemiology distinct from that found for SIVs in other African primate species.

Indexed as

Genetic VariationPhylogeographyTopography, MedicalAnimalsCameroonGabonHaplorhiniPrevalenceSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusbushmeatCameroonGabonguenonlentivirusnonhuman primatesimian immunodeficiency virusSIV prevalence

Identifiers

PMID28077632
PMCPMC5331790
OpenAlexW2574615419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.